Development of a Specific Scale of Life'Quality for Children With Low-flow Vascular Malformations
MVFL
Development and Validation of a Specific Scale of Life'Quality for Children With Low-flow Vascular Malformations Aged 11 to 15 Years-old.
2 other identifiers
interventional
300
1 country
3
Brief Summary
The low-flow malformations include venous and lymphatic malformations. The malformation often affects the skin and can extend deep to the muscles and bone, as well as to deep organs. Children with low-flow vascular malformation and their family have difficulty living with their illness and have an impact on their life quality. In this context, the aim of the study is to develope life quality test for the children between 11 to 15 years old.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2018
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2018
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedStudy Start
First participant enrolled
February 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2019
CompletedMarch 5, 2018
March 1, 2018
11 months
February 14, 2018
March 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Specific scale of life's quality for slow-flow vascular malformation
Specific scale of life's quality for slow-flow vascular malformation. * the preliminary version of which is created by transforming the qualitative categories resulting from the qualitative analysis of the verbatim into an exhaustive list of thematic items which will then be selected and sorted by the experts * and whose final version is obtained by the statistical validation analysis aimed at structural validity and unidimensionality and convergent and discriminant validity.
12 months
Study Arms (1)
Child with slow-flow malformation
OTHERPhase 1: Collect of experiences, perceptions, difficulties, needs and expectations of patients with slow-flow vascular malformation (for the age group of 11 to 15 years-old) using the focus group method. Phase 2 : Administration of the scale of life's quality for validation.
Interventions
First (phase 1), collect experiences, perceptions, difficulties, needs and expectations of patients with slow-flow malformations (for the age group of 11 to 15 years-old), carried out with 3 categories of participants and then (phase 2) development and validation of the specific scale of life's quality of slow-flow vascular malformation in children aged 11 to 15 years-old.
Eligibility Criteria
You may qualify if:
- Phase 1:
- Patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), aged 11 to 15 years-old.
- Patient with slow-flow vascular malformation, whatever its clinical form, its severity (clinical and imaging diagnosis), aged over 15 years-old.
- Parents of a patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), aged 11 to 15 years-old inclusive
- Patient affiliated to a social security scheme
- Patient having given his consent or for the minor whose legal representative has given written informed consent.
- Phase 2 :
- Patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), 11 to 15 years-old of age included.
- Patient affiliated to a social security scheme
- Patient having given his consent or for the minor whose legal representative has given his informed consent
You may not qualify if:
- For both phases: Pregnant or lactating women or girls,
- Vulnerable persons,
- Majors subject to a legal protection measure or unable to express their consent Phase 1: Patient or parent who does not speak the French language and therefore are unable to express themselves in the focus groups.
- Patient under 11 years-old; Phase 2 : Patient who does not speak French and is therefore unable to complete quality of life questionnaires
- Patient under 11 or over 15 years-old.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
UHBordeaux
Bordeaux, 33076, France
UHChambray
Chambray-lès-Tours, 37170, France
UHNantes
Nantes, 44093, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juliette Mazereeuw-Hautier, MD
University Hospital, Toulouse
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2018
First Posted
February 22, 2018
Study Start
February 23, 2018
Primary Completion
February 1, 2019
Study Completion
February 1, 2019
Last Updated
March 5, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share